Tibor Kovacsovics

6.4k total citations
123 papers, 3.7k citations indexed

About

Tibor Kovacsovics is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Tibor Kovacsovics has authored 123 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 51 papers in Molecular Biology and 34 papers in Genetics. Recurrent topics in Tibor Kovacsovics's work include Acute Myeloid Leukemia Research (63 papers), Multiple Myeloma Research and Treatments (26 papers) and Acute Lymphoblastic Leukemia research (25 papers). Tibor Kovacsovics is often cited by papers focused on Acute Myeloid Leukemia Research (63 papers), Multiple Myeloma Research and Treatments (26 papers) and Acute Lymphoblastic Leukemia research (25 papers). Tibor Kovacsovics collaborates with scholars based in United States, Switzerland and France. Tibor Kovacsovics's co-authors include Lewis C. Cantley, John H. Hartwig, Jeffrey E. Lancet, Daniel J. DeAngelo, Lloyd E. Damon, Anjali S. Advani, Christilla Bachelot‐Loza, Xavier Thomas, Norbert Vey and André Delannoy and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Tibor Kovacsovics

119 papers receiving 3.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tibor Kovacsovics 2.3k 1.4k 1.1k 880 639 123 3.7k
Carlos Graux 2.2k 0.9× 1.1k 0.8× 1.4k 1.3× 980 1.1× 581 0.9× 91 3.6k
Ellin Berman 2.2k 1.0× 1.2k 0.9× 871 0.8× 1.2k 1.4× 992 1.6× 99 3.8k
Daniela Cilloni 2.7k 1.2× 1.6k 1.2× 783 0.7× 848 1.0× 1.6k 2.5× 181 4.4k
Martin Höglund 3.4k 1.5× 1.5k 1.1× 1.1k 1.0× 1.2k 1.4× 1.6k 2.5× 134 5.1k
Renato Bassan 2.4k 1.0× 664 0.5× 2.1k 2.0× 1.2k 1.3× 983 1.5× 164 4.2k
Ellen K. Ritchie 2.4k 1.1× 1.4k 1.0× 736 0.7× 678 0.8× 1.2k 1.9× 172 3.6k
Albrecht Reichle 1.4k 0.6× 1.0k 0.7× 1.5k 1.4× 1.8k 2.0× 429 0.7× 125 3.8k
CH Pui 2.0k 0.9× 952 0.7× 2.5k 2.4× 613 0.7× 515 0.8× 64 3.8k
Yago Nieto 1.9k 0.8× 859 0.6× 439 0.4× 1.7k 2.0× 644 1.0× 242 4.0k
G.J. Ossenkoppele 1.6k 0.7× 783 0.6× 481 0.4× 1.1k 1.3× 677 1.1× 84 3.3k

Countries citing papers authored by Tibor Kovacsovics

Since Specialization
Citations

This map shows the geographic impact of Tibor Kovacsovics's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Kovacsovics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Kovacsovics more than expected).

Fields of papers citing papers by Tibor Kovacsovics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Kovacsovics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Kovacsovics. The network helps show where Tibor Kovacsovics may publish in the future.

Co-authorship network of co-authors of Tibor Kovacsovics

This figure shows the co-authorship network connecting the top 25 collaborators of Tibor Kovacsovics. A scholar is included among the top collaborators of Tibor Kovacsovics based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tibor Kovacsovics. Tibor Kovacsovics is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Peng, Margaret S. Williams, Thomas A. White, et al.. (2022). The genetic landscape of germlineDDX41variants predisposing to myeloid neoplasms. Blood. 140(7). 716–755. 43 indexed citations
2.
Sekeres, Mikkael A., Michael Schuster, Magalie Joris, et al.. (2022). A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes. Annals of Hematology. 101(8). 1689–1701. 11 indexed citations
3.
Li, Peng, Thomas A. White, Wei Xie, et al.. (2021). AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome. Leukemia. 36(3). 664–674. 36 indexed citations
4.
Kovacsovics, Tibor, et al.. (2020). Utility of Biomarkers in Cardiac Amyloidosis. JACC Heart Failure. 8(9). 701–711. 26 indexed citations
5.
Sekeres, Mikkael A., Michael W. Schuster, Magalie Joris, et al.. (2019). A Phase 1b Study of Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia. Blood. 134(Supplement_1). 177–177. 16 indexed citations
6.
Ludwig, Heinz, Andrew Spencer, Tibor Kovacsovics, et al.. (2017). Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study. Blood. 130. 3125–3125. 4 indexed citations
7.
Traer, Elie, Jacqueline Martinez, Nathalie Javidi‐Sharifi, et al.. (2016). FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia. Cancer Research. 76(22). 6471–6482. 96 indexed citations
8.
Yousef, Sara, Magdalena Kovacsovics‐Bankowski, Mohamed E. Salama, et al.. (2015). CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma. Human Vaccines & Immunotherapeutics. 11(7). 1606–1611. 31 indexed citations
9.
10.
Tyner, Jeffrey, Armand Bankhead, Guang Fan, et al.. (2012). Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening. Cancer Research. 73(1). 285–296. 100 indexed citations
11.
Laffitte, Emmanuel, Nicolas Widmer, Laurent A. Décosterd, et al.. (2005). Severe Pustular Eruption Associated with Imatinib and Voriconazole in a Patient with Chronic Myeloid Leukemia. Dermatology. 211(4). 363–365. 36 indexed citations
12.
Dhédin, Nathalie, Hervé Dombret, Xavier Thomas, et al.. (2005). Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials. Leukemia. 20(2). 336–344. 28 indexed citations
13.
14.
Halkic, Nermin, Riadh Ksontini, Tibor Kovacsovics, et al.. (2004). Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 51(1). 84–87. 15 indexed citations
15.
Keating, Michael J., Bruno Cazin, Steven Coutré, et al.. (2002). Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed. Journal of Clinical Oncology. 20(1). 205–213. 73 indexed citations
16.
Spataro, Vito, et al.. (2000). Acute Myeloid Leukemia in the Elderly: Results of an Individualized Approach in Two Centres. Leukemia & lymphoma. 39(5-6). 521–530. 10 indexed citations
17.
Cometta, Alain, et al.. (1997). PP18. Hospital costs of intensive chemotherapy followed by peripheral stem cell reinfusion. European Journal of Cancer. 33. S21–S21. 1 indexed citations
18.
Hartwig, John H., Tibor Kovacsovics, Paul A. Janmey, et al.. (1996). D3 Phosphoinositides and Outside-in integrin Signaling by Glycoprotein IIb-IIIa Mediate Platelet Actin Assembly and Filopodial Extension Induced by Phorbol 12-Myristate 13-Acetate. Journal of Biological Chemistry. 271(51). 32986–32993. 113 indexed citations
19.
Toker, Alex, Christilla Bachelot‐Loza, Ching‐Shih Chen, et al.. (1995). Phosphorylation of the Platelet p47 Phosphoprotein Is Mediated by the Lipid Products of Phosphoinositide 3-Kinase. Journal of Biological Chemistry. 270(49). 29525–29531. 64 indexed citations
20.
Peitsch, Manuel C., Tibor Kovacsovics, & Henri Isliker. (1988). A rapid and efficient method for the purification of the complement subcomponents C1r and C1s in zymogen form using fast protein chromatography. Journal of Immunological Methods. 108(1-2). 265–269. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Graux Breakdown of academic impact, for papers by Ellin Berman Breakdown of academic impact, for papers by Daniela Cilloni Breakdown of academic impact, for papers by Martin Höglund Breakdown of academic impact, for papers by Renato Bassan Breakdown of academic impact, for papers by Ellen K. Ritchie Breakdown of academic impact, for papers by Albrecht Reichle Breakdown of academic impact, for papers by CH Pui Breakdown of academic impact, for papers by Yago Nieto Breakdown of academic impact, for papers by G.J. Ossenkoppele
Rankless by CCL
2026